Newborn Eye Imaging Systems Market (By Disease Type: ROP, Retinal Disease, Strabismus, Refractive Error, Color Blindness, Others; By Device Type: Basic Device, Wireless Device; By End User: Hospitals, Ophthalmology Diagnosis Centers, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

The global newborn eye imaging systems market size was exhibited at USD 1.98 billion in 2022 and is projected to hit around USD 3.72 billion by 2032, growing at a CAGR of 6.51% during the forecast period 2023 to 2032.

Newborn Eye Imaging Systems Market Size, 2023 to 2032

Key Pointers:

  • By geography, North America generated more than 34.79% of revenue share in 2022.
  • By geography, Europe gained a notable share of around 25.68% in 2022 and will grow at the quickest rate from 2023 to 2032.
  • By disease type, the ROP segment accounted for more than 37.41% of revenue share in 2022. 
  • By disease type, the retinal disease segment is progressing at a CAGR of 6.8% from 2023 to 2032.
  • By device type, the basic device segment captured around 55.99% of revenue share in 2022. 
  • By device type, the wireless device segment is growing at a CAGR of 7.2% from 2023 to 2032.
  • By end user, the hospital segment generated around 38.49% of revenue share in 2022.
  • By end user, the ophthalmology & diagnosis center segment is growing at a CAGR of 6.9% from 2023 to 2032.

Newborn Eye Imaging Systems Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 2.11 Billion

Market Size by 2032

USD 3.72 Billion

Growth Rate From 2023 to 2032

CAGR of 6.51%

Base Year

2022

Forecast Period

2023 to 2032

Segments Covered

By Disease Type, By Device Type and By End User

Market Analysis (Terms Used)

Value (US$ Million/Billion) or (Volume/Units)

Regional Scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key Companies Profiled

Visunex Medical Systems, Eye Photo Systems, MergeHealthcare, D-EYE, Imagine Eyes, Natus MedThe driving factors of the newborn eye imaging systems market are theical, Servicom Medical and Others.

 

Eye imaging system is a type of device that helps in recognizing the eye related problems. The increasing number of the people that are suffering from various eye disorders has increased considerably. The new born babies also undergo from eye problems such as retinopathy of prematurity (ROP) which may result in the loss of eye sight and affects the blood cells.

The rapidly rising numbers of babies that are suffering from eye problems across the world is amongst the important factors intensifying the growth and demand of new born eye imaging systems market. In addition, the various market players in the new born eye imaging systems market are looming with advanced devices and technologies for the imaging purpose as well as are raising funds for the research activities which are also largely contributing to the growth in the global market over the forecast period of 2021 to 2028. Also, the growing number of new born population that is affected with eye related problems is also one of the significant factors fueling the growth of the new born eye imaging systems market.

The rapidly increasing approval of the product from respective organization and rapid technological advancements by various market players will further accelerate the expansion of the new born eye imaging systems market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.

However, the high cost as well as lack of awareness regarding the product will curb the growth of the new born eye imaging systems market, whereas the dearth of trained professionals and increasing adoption of refurbished imaging systems have the potential to challenge the growth of the new born eye imaging systems market.

This new born eye imaging systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on new born eye imaging systems market contact Data Nova one advisor for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Some of the prominent players in the Newborn Eye Imaging Systems Market include:

  • Visunex Medical Systems
  • Eye Photo Systems
  • MergeHealthcare
  • D-EYE
  • Imagine Eyes
  • Natus Medical
  • Servicom Medical

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Newborn Eye Imaging Systems market.

By Disease Type

  • ROP 
  • Retinal Disease 
  • Strabismus 
  • Refractive Error 
  • Color Blindness 
  • Others

By Device Type

  • Basic Device
  • Wireless Device 

By End-User

  • Hospitals
  • Ophthalmology Diagnosis Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global newborn eye imaging systems market size was exhibited at USD 1.98 billion in 2022 and is projected to hit around USD 3.72 billion by 2032

The global newborn eye imaging systems market is poised to grow at a CAGR of 6.51% from 2023 to 2032.

The major players operating in the newborn eye imaging systems market are Visunex Medical Systems, Eye Photo Systems, MergeHealthcare, D-EYE, Imagine Eyes, Natus MedThe driving factors of the newborn eye imaging systems market are theical, Servicom Medical and Others.

North America region will lead the global newborn eye imaging systems market during the forecast period 2023 to 2032.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Newborn Eye Imaging Systems Market 

5.1. COVID-19 Landscape: Newborn Eye Imaging Systems Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Newborn Eye Imaging Systems Market, By Disease Type

8.1. Newborn Eye Imaging Systems Market, by Disease Type, 2023-2032

8.1.1 ROP

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Retinal Disease

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Strabismus

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Refractive Error

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Color Blindness

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Newborn Eye Imaging Systems Market, By Device Type

9.1. Newborn Eye Imaging Systems Market, by Device Type, 2023-2032

9.1.1. Basic Device

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Wireless Device

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Newborn Eye Imaging Systems Market, By End-User 

10.1. Newborn Eye Imaging Systems Market, by End-User, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Ophthalmology Diagnosis Centers

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Ambulatory Surgical Centers

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Newborn Eye Imaging Systems Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Disease Type (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 12. Company Profiles

12.1. Visunex Medical Systems

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Eye Photo Systems

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. MergeHealthcare

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. D-EYE

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Imagine Eyes

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Natus Medical

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Servicom Medical

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers